Form 4: Inari Medical Director Rebecca Chambers Reports Stock Sale
SEC Form 4 Filing
Director Rebecca Chambers sold 964 shares of Inari Medical (NARI) at $45.39 per share on May 20, 2024, according to a Form 4 filing.
Summary
- Rebecca Chambers, a director at Inari Medical, Inc. (NARI), reported a transaction involving the sale of company stock.
- On May 20, 2024, Chambers sold 964 shares of common stock at a price of $45.39 per share.
- The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 6, 2023.
- Following the reported transaction, Chambers directly owns 9,944 shares of Inari Medical stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it reports a routine stock sale by a company director under a pre-arranged trading plan. There is no indication of positive or negative implications for the company's performance.
Industry Context
This filing is a routine disclosure of insider trading activity. It provides transparency to the market regarding the transactions of company insiders.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| 2023-07-26 | Date of Power of Attorney execution. |
| 2023-12-06 | Date Rebecca Chambers adopted the Rule 10b5-1 trading plan. |
| 2024-05-20 | Date of the stock sale transaction. |
| 2024-05-21 | Date of the Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.